Model
Edge
Moonlake Immunotherapeutics
0001920545
Filing Type
4
Filing Date
4/6/2023
Updated
4/7/23, 10:05 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership